CVS Health To Split Into Two Publicly Traded Companies By 2028

CVS Health reported Q3 2026 earnings of $2.09 per share, beating estimates, with revenue at $108 billion. Despite this, its stock fell 12.5% on the day, while peers like Elevance Health rose. Operating income increased year-over-year to $3.57 billion. Management raised its 2026 EPS outlook and expects growth in 2027, but the Health Services segment faces challenges. CVS plans to split into two companies by mid-2028.

CVS Health plans to split into two companies, undoing its 2018 $78 billion merger. The company will separate its retail stores from its pharmacy benefit management and insurance arm.

CVS EVP Prem Shah bought 23,855 shares for $2.0M at $83.89 on Nov 6, 2026, two days after a 12.5% stock drop due to a planned spin-off. Shah, who will lead the retail spin-off, increased his stake by 37%. Goldman Sachs lowered its price target to $115 from $120.

CVS Health plans to split into two publicly traded companies, separating its pharmacy and insurance businesses. The move, announced after a board review, comes amid regulatory challenges and a 12.5% drop in shares to $79.96. The new entities will be CVS Pharmacy and a healthcare solutions company including Aetna and CVS Caremark, according to the company.

CVS is splitting its retail pharmacy business from its healthcare solutions and insurance operations. The company claims the two entities will operate independently, but experts have mixed views on potential drug pricing impacts. CVS Pharmacy will include 9,000 retail locations and MinuteClinic, while the healthcare solutions company will comprise Aetna and other health services.

Humana (HUM) gained 16.5% after its Medicare Advantage plan improved to four stars, restoring federal bonus eligibility. Analysts expect $4.8B in bonuses in 2028. UnitedHealth (UNH) and CVS (CVS) saw declines in four-star-plus plan memberships. Humana's 2027 EPS is projected to rebound to $17.31 after a 47% drop in 2026.